Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: The Canadian Bladder Cancer Network experience

BJU International

Volumn 110, Issue 9, 2012, Pages 1317-1323

  Yafi, Faysal A ^a   Aprikian, Armen G ^a   Fradet, Yves ^c   Chin, Joseph L ^d   Izawa, Jonathan ^d   Rendon, Ricardo ^f   Estey, Eric ^g   Fairey, Adrian ^g   Cagiannos, Ilias ^e   Lacombe, Louis ^c   Lattouf, Jean Baptiste ^b   Bell, David ^f   Saad, Fred ^b   Drachenberg, Darrel ^h   Kassouf, Wassim ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h Department of Surgery ^*  (Canada)

Author keywords

bladder cancer; lymphadenectomy; muscle invasive; radical cystectomy

Indexed keywords

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; BLADDER CANCER; BONE TUMOR; BRAIN TUMOR; CANADA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CYSTECTOMY; FOLLOW UP; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; PELVIS TUMOR; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SALVAGE THERAPY; SYSTEMIC THERAPY; THORAX RADIOGRAPHY; TUMOR LOCALIZATION; TUMOR RECURRENCE;

EID: 84867747131     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11133.x     Document Type: Article

References (35)

1. Marrett LD, De P, Dryer D, Steering Committee of Canadian Cancer Statistics 2008. Cancer in Canada in 2008. CMAJ 2008; 179: 1163-70
2. Madersbacher S, Hochreiter W, Burkhard F, et al,. radical cystectomy for bladder cancer today- a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 4: 690-6
3. Ghoneim MA, Abdel-Latif M, El-Mekresh M, et al,. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 2008; 180: 121-7
4. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75
5. Shariat SF, Karakiewicz PI, Palapattu GS, et al,. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-22
6. Yafi FA, Aprikian AG, Chin JL, et al,. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int 2010; 108: 539-45
7. Donat MS,. Evaluation and follow-up strategies for superficial bladder cancer. Urol Clin North Am 2003; 30: 765-76
8. Montie JE,. Follow-up after cystectomy for carcinoma of the bladder. Urol Clin North Am 1994; 21: 639-43
9. Sandock DS,., Seftel A, Resnick MI,. A new protocol for the follow-up of renal cell carcinoma based on pathological stage. J Urol 1995; 154: 28-31
10. NCCN Clinical Practice Guidelines in Oncology. Bladder Cancer 2012. Available at: http://www.nccn.com. Accessed 19 March 2012
11. Stenzl A, Witjes JA, Comperat E, et al,. Guidelines on bladder cancer muscle-invasive and metastatic, 2012. Available at: http://www.uroweb.org. Accessed 19 March 2012
12. Bellmunt J, Albiol S, Kataja V,. Invasive bladder cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19: 47-8
13. Knap MM, Lundbeck F, Overgaard J,. Prognostic factors, pattern of recurrence and survival in Danish bladder cancer cohort treated with radical cystectomy. Acta Oncol 2003; 42: 160-8
14. Hassan JM, Cookson MS, Smith JA Jr, Chang SS,. Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol 2006; 175: 2054-7
15. Slaton JW, Swanson DA, Grossman HB, Dinney CPN,. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1999; 162: 710-4
16. Holmang S, Hedelin J, Anderstrom C, Holmberg E, Johansson SL,. Long-term followup of a bladder carcinoma cohort: routine followup urography is not necessary. J Urol 1998; 160: 45-8
17. Westney LO, Pisters LL, Pettaway CA, Dinney CPN, et al,. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1998; 159: 792-5
18. Honma I, Masumori N, Sato E, et al,. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urolog 2004; 64: 744-8
19. Yu JR, Stein JP, Cai J, Skinner DG, et al,. Superficial (pT2a) and deep (pt2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol 2006; 176: 493-9
20. Pisters LL, Westney L,. The management of locally recurrent invasive bladder cancer following radical cystectomy. Semin Urol Oncol 1996; 14: 112-9
21. Greven KM, Spera JA, Hanks GE, et al,. Local recurrence after cystectomy alone for bladder carcinoma. Cancer 1992; 69: 2767-70
22. Lotan Y, Gupta A, Shariat SF, et al,. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radial cystectomy. JCO 2006; 23: 6533-9
23. Donat MS,. Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? World J Urol 2006; 24: 557-64
24. Hautmann RE, Volkmer BG, Schumacher MC, Gschwend JE, Studer UE,. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 2006; 24: 305-14
25. Lin DW, Herr HW, Dalbagni G,. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol 2003; 169: 961-3
26. Knapik JA, Murphy WM,. Urethral wash cytopathology for monitoring patients after cystoprostatectomy with urinary diversion. Cancer 2003; 99: 352-6
27. Braslis KG, Soloway MS,. Management of ureteral and renal pelvic recurrence after cystectomy. Urol Clin North Am 1994; 21: 653-9
28. Meissner C, Giannarini G, Schumacher MC, et al,. The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol 2007; 178: 2287-90
29. Hastie KJ, Hamdy FC, Collins MC, et al,. Upper tract tumours following cystectomy for bladder cancer. Is routine intravenous urography worthwhile? Br J Urol 1991; 67: 29-31
30. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL,. Longterm followup of a bladder carcinoma cohort: routine followup urography is not necessary. J Urol 1998; 160: 45-8
31. Mardersbacher S, Schmidt J, Eberle JM, et al,. Long-term outcome of ileal conduit diversion. J Urol 2003; 169: 985-90
32. Volkmer BG, Kuefer R, Bartsch GC, Gust K Jr, Hautmann RE,. Oncological follow-up after radical cystectomy for bladder cancer-is there any benefit? J Urol 2009; 181: 1587-93
33. Giannarini G, Kessler TM, Theony HC, Nguyen DP, Meissner C, Studer UE,. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 2010; 58: 486-94
34. Zecha H, Schmid HP, Tschopp A, Sulser T, Engeler DS,. High incidence of independent second malignancies after non-muscle-invasive bladder cancer. Scand J Urol Nephrol 2011; 45: 245-50
35. Dalbagni G, Bochner BH, Cronin A, Herr HW, Donat SM,. A plea for a uniform surveillance schedule after radical cystectomy. J Urol 2011; 185: 2091-6